Thalidomide derivatives (IMAGE)
Caption
The thalidomide derivatives C5, C6 and C7 alter CRBN – the “labeling machine” – so that it can bind to BCL-2. In this way, the BCL-2 molecule is marked for degradation – a possible new strategy against cancer.
Credit
Dr. Xinlai Cheng, Goethe University Frankfurt
Usage Restrictions
To be used only when reporting on Goethe University Frankfurt. Indicate copyright: Dr. Xinlai Cheng, Goethe University Frankfurt
License
Original content